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ABSTRAK 
 
Sejak penemuan awal antigen D pada tahun 1939, 50 antigen berkaitan telah diberikan 
kepada sistem kumpulan darah Rh oleh Persatuan Antarabangsa Transfusi Darah 
(ISBT). Di antaranya lima antigen utama iaitu D, C, c, E dan e adalah yang paling 
penting. Ujian antigen RhD telahpun diwajibkan sebelum proses mengeluarkan darah 
yang serasi dalam perubatan transfusi disebabkan oleh immunogenisitas antigen D 
bersama-sama dengan kumpulan darah ABO. Uniknya Sarawak dengan berbilang kaum 
dan perkahwinan campur mempunyai kesan yang besar ke arah taburan Rh fenotip dan 
genotip paling mungkin di kalangan penderma darah tetap di Sarawak. Namun sehingga 
masa kini, tiada sebarang kajian tentang antigen utama Rh, fenotip dan genotip paling 
mungkin yang telah dilakukan di kalangan penduduk Sarawak. Kajian ini telah 
dijalankan di Tabung Darah, Jabatan Patologi, Hospital Umum Sarawak (HUS) dari 
bulan Januari hingga Februari 2015 yang melibatkan 155 Iban, 128 Cina, 123 Melayu, 
43 Bidayuh, 32 Orang Ulu dan 27 Melanau. Sampel darah daripada 508 subjek telah 
diuji untuk kumpulan darah ABO dengan menggunakan kaedah aglutinasi tiub dan lima 
antigen utama Rh sistem kumpulan darah diuji melalui kaedah kad gel. Untuk sistem 
kumpulan darah ABO, didapati kumpulan darah O (37.80%) dan B (32.28%) adalah 
kumpulan darah yang paling biasa ditemui di kalangan penduduk Sarawak. Kejadian 
RhD adalah 99.80% dan 0.20% sampel negatif untuk antigen D. Insiden antigen Rh 
yang lain seperti C, E, c dan e adalah sebanyak 95.87%, 31.89%, 35.43% dan 97.05% 
masing-masing. Antigen yang paling kerap ditemui di antara lima antigen utama adalah 
RhD dan yang paling jarang dijumpai adalah antigen E. Fenotip yang paling biasa 
dijumpai dalam RhD sampel positif adalah DCCee (60.24%) dan di RhD sampel negatif 
adalah dccee (0.20%). Genotip paling mungkin mengikut urutan kekerapan adalah 
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CDe/CDe (R1R1) – 60.24%, CDe/cDE (R1R2) – 23.23% dan CDe/cde (R1r) – 7.28%. 
Sementara itu, genotip kemungkinan yang paling kerap ditemui adalah cde/cde (rr) 
dalam sampel Rh negatif. Fenotip kurang biasa termasuk CDE/CDE (RzRz) dan cDe/cde 
(R0r ) – 0.20% setiap satu, telah ditemui di kalangan subjek Iban dalam kajian ini. 
Fenotip luar biasa yang jarang ditemui iaitu -D-/-D- (Rh17) telahpun dikesan dalam 
salah seorang penderma darah Bidayuh (0.20%). Kajian ini juga membuat kesimpulan 
bahawa gen Rh dan fenotip adalah berbeza-beza secara meluas di kalangan bangsa 
berlainan dan sempadan geografi. Secara ringkasnya, kajian ini telah berjaya 
mewujudkan satu sistem pangkalan data dan membandingkan taburan antigen Rh, 
fenotip dan genotip paling mungkin untuk enam kumpulan etnik utama di Sarawak. 
Sistem pangkalan data yang ditubuhkan daripada kajian ini akan memberikan manfaat 
yang besar dan amat penting untuk perkhidmatan pemindahan darah tempatan pada 
masa akan datang. 
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ABSTRACT 
 
Since the initial discovery of the D antigen in 1939, 50 related antigens have been 
assigned to the Rh blood group system by the International Society of Blood 
Transfusion (ISBT), among which the antigens D, C, c, E and e are the most essential. 
RhD antigen testing was made compulsory before issuing a compatible blood in 
transfusion medicine due to its potent immunogenicity along with ABO grouping. 
Uniquely Sarawak with multi-racial and intermarriage have substantial effect towards 
the distribution of Rh phenotype and most probable genotype among the regular blood 
donors in Sarawak. Until now, there is no study presented in major Rh antigens, its 
phenotype and most probable genotype in the Sarawak's population. This study was 
carried out at Blood Bank, Department of Pathology, Sarawak General Hospital from 
January to February 2015 involving 155 Iban, 128 Chinese, 123 Malay, 43 Bidayuh, 32 
Orang Ulu and 27 Melanau. Blood samples collected from 508 subjects were tested for 
ABO blood group by using the tube agglutination method and five major Rh antigens 
via gel technology. For the ABO system, blood group O (37.80%) and B (32.28%) are 
the most common blood group found among the Sarawak's population. Incidence of 
RhD was 99.80% and only 0.2% samples negative for D antigen. The incidence of other 
Rh antigens such as C, E, c and e was 95.87%, 31.89%, 35.43% and 97.05% 
correspondingly. Antigen D was the most frequent antigen amongst five major antigens 
and the least common was antigen E. Most common phenotype in D-positive samples 
was DCCee (60.24%) and in D-negative was dccee (0.20%). Most probable genotype in 
order of frequency was CDe/CDe (R1R1) ˗ 60.24%, CDe/cDE (R1R2) ˗ 23.23% and 
CDe/cde (R1r) ˗ 7.28%. Meanwhile, the most frequent probable genotype was cde/cde 
(rr) in Rh negative samples. Less common phenotypes found in this study were 
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CDE/CDE (RzRz) and cDe/cde (R0r) ˗ 0.20% each, which was predominant in Iban 
subjects. Unusual rare phenotype –D-/-D- (Rh17) was revealed in one of the Bidayuh 
subject (0.20%). This present study concluded that Rh genes and phenotypes vary 
widely across races and geographical boundaries. In conclusion, this study has managed 
to establish the database and compare the distribution of Rh antigens, its phenotype and 
most probable genotype among six major ethnic groups in Sarawak. The established 
database will be of great benefit and importance in the future local blood transfusion 
service. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
CHAPTER 1 
 
INTRODUCTION 
 
1.1 The Rh blood group system and problem  
 
Up to now, ABO and Rh blood group systems are the most vital elements in transfusion 
science and medicine among other blood group system and antigens discovered (Sharma et 
al., 2010). Since the early discovery of the D antigen in 1939, 50 related antigens have been 
assigned to the Rh system by the International Society of Blood Transfusion (ISBT). The 
major, and the most important antigens are D, C, c, E, and e are which account for most 
clinical transfusion issues (Blaney and Howard, 2013). 
 
The presence or absence of the D antigen determines whether an individual is Rh positive 
and Rh negative refer to; more accurate terms are D-positive and D-negative. Rh blood 
group systems play an important role in blood transfusion practice. Additionally, the D 
antigen has serious clinical effects, causing hemolytic disease of the fetus and newborn 
(HDFN) as prevention is the best approach to the management of this disorder. In 1940, 
Levine and Stetson had linked the cause of HDFN to the Rh blood group due to the 
similarity of this antibody obtained from guinea pigs and rabbits immunized with rhesus 
monkey red cells, and so the blood group system was named Rh for rhesus monkey 
(McCullough, 2011). 
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In order to elucidate the inheritance and to classify the most complex Rh blood group 
system, four theories have been recommended. There are two nomenclatures that are used 
interchangeably: the Weiner 1939 and Fisher-Race 1940. Two added systems: Rosenfield 
1960 and International Society of Blood Transfusion (ISBT) were established because of a 
need for a universal language compatible with computers (Daniels et al., 1995). 
 
The Malaysian blood donor population is composed of three major ethnic groups (Malay, 
Chinese and Indian) and other minor ethnic groups (e.g. native people from East Malaysia). 
As the donor population is quite heterogeneous, the distribution of Rh phenotypes and 
genotypes to diverge as well. Known as Bumi Kenyalang, Sarawak is one of two Malaysian 
states on the island of Borneo. It is the most diverse, in terms of its physical features, 
traditional cultures, population as well as its modern history (Douglas and Douglas, 1999). 
 
The population in Sarawak is very varied; consisting of 27 ethnic groups and 40 sub-ethnic 
groups, each with its own different language, culture and custom, and lifestyle system. This 
unique characteristic makes Sarawak demography very distinct compared to its peninsular 
counterpart (Kenyalang and Negeri). Intermarriage between ethnic groups in Sarawak has 
been common for generations. But until lately most of the mixed marriages have been 
between indigenous groups with parallel backgrounds.  
 
Undoubtedly, multi-racial and intermarriage have significant effect towards the distribution 
of Rh antigens, its phenotype or most probable genotype among the regular blood donors in 
Sarawak based on unpublished BBIS (Blood Bank Information System) Enteral DarahLink 
system. As yet, there is no published data in prevalence of Rh antigens, its phenotype or 
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most probable genotype among the population of Sarawak. It is therefore timely to conduct 
a related study to establish local database on Rh phenotype/genotype among Sarawak's 
population. 
 
In this study, prevalence of Rh antigens, phenotype or probable genotype of the regular 
blood donors will only be done confined to Sarawak General Hospital (SGH) and Hospital 
Miri due to the restricted time frame and budget constraint. This research is going to be 
conducted in SGH because of its status as a regional referral centre, and provide a wide 
range of inpatient and outpatient care in addition to the high number of blood donations that 
it receive daily. Hospital Miri is a secondary referral hospital in the northern region of 
Sarawak. 
 
The established database from this study will be of great benefit and importance in the 
future local blood transfusion service. This is particularly important in instances where 
blood for patients with certain antibody requiring urgent transfusion can be quickly 
phenotyped from prospective donors from the ethnic group with the highest prevalence of 
that particular blood group.  Apart from that, established database from the study can be 
used to support the National Donor Data Registry Program which will be held by National 
Blood Centre (NBC). Well established data which will be reported yearly is important to 
help more people who have difficulty in finding a matching blood donor when urgent blood 
transfusion is obligatory. The growth in numbers of voluntary blood donors, plus the 
diversity of races and ethnicities on the registry, is improving all patients' chances of 
finding the matched blood they need. 
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1.2 Objectives 
General objective: To determine the prevalence of Rh antigens, its phenotype or most 
probable genotype among regular blood donors in Sarawak  
 
Specific objectives:  
i. To classify the frequency of Rh antigens, phenotype or most probable genotype 
based on 6 major ethnic groups in Sarawak's population  
ii. To assess the D--/D-- among regular blood donors in SGH and Hospital Miri 
including 6 major ethnic groups in Sarawak's population  
iii. To compare the prevalence of Rh antigens, phenotype or probable genotype among 
regular blood donors in Sarawak's population with major ethnic groups (Malay, 
Chinese and India) in other studies 
 
1.3  Hypothesis 
 
 Null hypothesis, H0: There is no difference between Sarawak regular blood donors and 
Peninsular Malaysian in term of Rh antigens, its phenotype or probable genotype 
 
 Alternative hypothesis, H1: Regular blood donors in Sarawak have different Rh antigens, its 
phenotype or probable genotype compared to its peninsular counterpart due to multi-racial, 
multi-ethnics and intermarriage in Sarawak 
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1.4  Literature review 
 
1.4.1  The Rh blood group system 
 
The highly complex and polymorphic Rh system is the second most essential red cell 
antigen system after the ABO system. At present, the Rh blood group system is comprised 
of some 50 different blood-group antigens. Five are of particular importance including 
antigens D, C, c, E, and e (Blaney and Howard, 2013). The presence or absence of the D 
antigen determines whether an individual is Rh positive or Rh negative. An individual 
whose red cells express the D antigen are termed Rh positive and those whose red cells do 
not express the D antigen are termed Rh negative. 
 
C, c, E and e are the other four principal antigens identified that seemed to be embedded in 
the cell membrane bilayer in unique configurations and became part of the Rh blood group 
system. These five major antigens, along with their corresponding antibodies, account for 
most of the Rh-related clinical transfusion issues. In contrast to the ABO blood group, Rh 
blood group system antibodies are usually made by exposure to Rh antigens through blood 
transfusion or during pregnancy in women (Blaney and Howard, 2013). 
 
Clinically, the Rh factor, like ABO factors, can cause potential clinical effects, initiating an 
adverse transfusion reactions or hemolytic disease of the fetus and newborn (HDFN). The 
greatest problem with the Rh blood group occurs when a mother's blood type conflicts with 
that of her newborn child. In addition to the clinical importance of the Rh system, 
determination of Rh blood group has been useful in population genetic studies and 
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migration pattern as well as resolving medico-legal issues. Thus, it is essential to have 
information on the distribution of these blood groups in any population groups. 
 
1.4.2  History of discoveries 
 
The first case of Rh incompatibility was reported in 1939 by Levine and Stetson. They 
published their case of a woman who delivered a stillborn fetus affected by hemolytic 
disease of the newborn. She developed a severe transfusion reaction upon receiving a blood 
transfusion from her husband though both of them were of blood-type O. Further tests 
indicated that the woman had become immunized specifically to a factor that she lacked 
which her child had inherited from the father. However, no name was specified to 
this agglutinin when described for the first case report (Simon et al., 2011).  
 
In early 1940, Levine and Stetson linked the cause of hemolytic disease of the newborn to 
the Rh blood group system. Rh was the name given to the system because of the similarity 
of this antibody to one made from stimulating guinea pigs and rabbits with rhesus monkey 
red cells (Macaques mulatta). This serum had a pattern of reactivity similar to that of 
Levine and Stetson's patient. Besides agglutinated the monkey red cells, this Rh antibody 
also agglutinated about 85% of white people red cells tested and was nonreactive with 15% 
(Smart and Armstrong, 2008). The population was characterized as Rh-positive or Rh-
negative from this discovery. 
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Later work established that the Rh antibody made from the guinea pigs and rabbits was 
similar, but not identical, to the human Rh antibody. The Rh antibody specificity was 
actually directed toward another different red cell antigen. However, the nomenclature was 
established by that time, and this antigen was named LW in honor of the discoverers (Scott, 
2004). The name of Rh blood group system had been established by then and was not 
changed. 
 
1.4.3  Rh nomenclature 
 
1.4.3.1   Fisher Race: CDE Terminology 
 
The Fisher-Race system postulated three closely linked loci, each with its own gene and 
gene product. D gene is inherited at one locus, C or c are inherited at the second locus, and 
E or e genes are inherited at the third locus. Each parent contributes one haplotype or set of 
Rh genes. Each gene with the exception of 'd' codes for a specific antigen that can be 
detected on the red cell membrane. It is possible that 'd' is a silent allele, and no anti-d has 
been found so far (Smart and Armstrong, 2008). The 'd' is still sometimes written to denote 
the absence of the D antigen. According to the Fisher-Race theory, the order of the genes 
on the chromosome is DCE to represent the co-location of the C and E encoding on the 
RhCE gene accurately. However, it is often written alphabetically as CDE (Blaney and 
Howard, 2013). The Fisher-Race theory is most widely used in transfusion practice since 
they can fit easily with most of the serologic reaction obtained. 
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1.4.3.2  Wiener: Rh-Hr Terminology 
 
In contrast to the Fisher-Race theory, Wiener system assumes the gene product was a single 
entity comprising a variable number of blood factors. Each parent contributes one Rh gene. 
Each gene product produced a multiple serologic specificities agglutinogen which could 
react with various antibodies. The gene complex or agglutinogen is made up of factors that 
are identifiable as separate antigens (Smart and Armstrong, 2008). 
 
According to Wiener system, there are eight alleles: R1, R2, Ro, Rz, r', r", r and ry exist at the 
Rh gene locus. The gene codes a structure on the red cells called agglutinogen, which can 
be recognized by its factors. These factors are identified with the same antisera that 
agglutinate the D, C, c, E and e antigens which had been mentioned in the Fisher-Race 
system. The dissimilarity between the Wiener and Fisher-Race theories is the inheritance of 
the Rh blood group system on a single gene locus rather than three separate genes (Blaney 
and Howard, 2013). 
 
Wiener terminology can be straightforwardly translated to Fisher-Race terminology when 
the following points are kept in mind: R is the same as D; r indicates no D antigen; the 
number 1 and the character ' denote C; and the number 2 and the character " denote E 
(Blaney and Howard, 2013). Nevertheless, Wiener: Rh-Hr terminology is unwieldy for 
routine use due to its complexity. 
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1.4.3.3  Rosenfield: Numeric Terminology 
 
Both the Fisher-Race and the Wiener terminologies are based on genetic concepts. The 
Rosenfield system was developed later to communicate phenotypic information more 
appropriate for computerized data entry. It does not address genetic information (Blaney 
and Howard, 2013).  
 
In 1962, a third terminology for the Rh system was introduced by Rosenfield in which each 
antigen was assigned a number, and the serologic reactions were used. The phenotype of a 
cell is expressed by the Rh followed by a colon and the numbers corresponding to the tested 
antigens. If a red cell sample is negative for the D antigen, a minus sign is written before 
the number as Rh:−1 (minus one) (Smart and Armstrong, 2008). This numeric designation 
for Rh antigens is an anticipation of the computer era. The numeric terms are not far and 
wide used in the clinical laboratory, except for Rh17, Rh29, Rh32 and Rh33 (Simon et al., 
2011). 
 
1.4.3.4  International Society of Blood Transfusion (ISBT) 
 
In an effort to develop and maintain standardized guidelines for blood group antigen and 
allele nomenclature, the ISBT, assigned a six-digit number to each specific blood group. The 
first three numbers symbolize the system and the remaining three characterize the antigen 
specificity. The assigned number of the Rh blood group system is 004 (Table 1.1) and the 
remaining three numbers correspond to the Rosenfield system. An ISBT alphanumeric 
designation similar to the Rosenfield terminology is used to mention to a specific antigen. The 
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term Rh is written in uppercase letters and the antigen number immediately follows the 
system designation. The ISBT number for the C antigen is 004002 and the ISBT symbol for C 
is RH2 (Blaney and Howard, 2013). 
 
Table 1.1: Currently recognized antigens within blood group systems 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11 
 
1.4.3.5    Determining the genotype from the phenotype 
 
The term phenotype actually refers to the variety of antigens detectable on red cells using 
specific antisera; and the term genotype refers to the genetic makeup of an individual. Five 
antisera, used to determine the Rh blood group system phenotypes, include anti-D, anti-C, 
anti-c, anti-E and anti-e. 
 
The genotype can be inferred precisely from the phenotype in many blood group systems. 
However, determination of genotype based on phenotype is not applicable in the Rh blood 
group system. In Rh system, any one antigen may derive from any of several genes, the 
genotype cannot be absolutely determined from the detecting antigens. It is necessary to do 
family studies or molecular testing to determine the genotype with more certainty, which 
are always unlikely. When the phenotype is known, the most probable genotype can be 
inferred based on the frequency of genes in a population (Table 1.2) (ME and C., 2004).  
 
For example, if a red cell specimen is typed as D+, C+, E-, c+, e+, the phenotype (antigens 
detected on the red cells) would be CcDe. When the genotype is inferred generally in the 
white population, the most common D positive genotype is CDe/ce or R1r. In the black 
population, the most probable genotype would be CDe/cDe or R1R0 because R0 allele is 
more common than the r allele. Meanwhile, the most common D negative genotype is ce/ce 
or rr (Blaney and Howard, 2013, Knight, 2012). 
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Table 1.2: The most probable phenotype (% occurrence) based on gene frequency in the 
population 
 
1.4.4     Rh system antigens 
 
A major step forward in understanding the Rh system was the isolation of Rh antigen 
containing components of the red cell membrane (Cartron, 1999). The D antigen is a 30-kD 
erythrocyte membrane protein which is associated with the red cell membrane skeleton. 
The transmembrane proteins probably traverse the membrane several times, which structure 
suggests that they are ion channels. Rh antigens D, C, c, E and e are encoded by two 
adjacent gene loci, namely RHD and RHCE. The RHD gene encodes the RhD protein with 
the D antigen and the RHCE gene encodes both the Cc and Ee polypeptides. There are four 
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alleles at this locus: RHCE, RHCe, RhcE and Rhce (Figure 1.1). D-negative individuals do 
not have the RHD gene and thus that RhD polypeptide. This explains why there is no 'd' 
antigen (McCullough, 2011, Daniels, 2008).  
 
 
 
 
 
 
 
 
 
Figure 1.1: Molecular basis of RHCE antigens 
 
1.4.4.1  D antigen 
 
The D antigen is a potent immunogen. An immunogen is any antigen that is capable to 
elicit an immune response instead of immunological tolerance. From the clinical viewpoint, 
the D antigen is the most significant blood group polymorphism. Up to 85% of Rh-negative 
individuals will produce an antibody with anti-D specificity if given an Rh-positive blood. 
For that reason, a D-negative patient should receive D-negative RBC unit when blood 
transfusion is indicated (Kelton et al., 1984). Routine typing for C and E antigens is not 
performed as these antigens are not as immunogenic as D.  
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1.4.4.1.1    Weak D 
 
Most red cells can be typed directly for the D antigen with certain anti-D reagents. 
Although the antibody to D is typically of the IgG class, reagent manufacturers have 
developed monoclonal anti-D antisera that can be used concomitantly with anti-A and anti-
B testing.  
 
Some individuals who inherit the quantitative weak D phenotype have red cells that react 
weakly, even though in most cases all immunogenic D epitopes are present (ME and C., 
2004). Due to low avidity of the antibody, monoclonal anti-D could fail to react with weak 
D cells instead of complete loss of the epitope (Daniels, 2008). 
 
Red cells that are negative for both anti-D reagent at immediate spin (IS) and after 37 °C 
incubation; but positive for D only by the IAT referred to as weak D phenotype. The D 
control tested at the IAT phase determines whether patient cells are already coated with IgG 
antibodies before testing. Reagent manufacturers specify the use of controls in their 
package inserts and it is vital to become familiar with these guidelines (Blaney and 
Howard, 2013). Weaker D expression can result from several different genetic 
circumstances.  
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1.4.4.1.2 Weak D: Genetic 
 
Some RHD genes code for a weaker expression of the D antigen. The reason for the 
weakened expression of the D antigen in these individuals is unknown. The molecular basis 
of weakly expressed D gene is heterogenous and has been related with the presence of 
several point mutations in RHD (Simon et al., 2011). Hereditary weak D is characterized 
serologically as non-agglutinating RBCs antibodies with anti-D typing reagents. An 
indirect anti-globulin test (IAT) using anti-D is usually required to detect this form of D. 
This quantitative variation in the RHD gene is more common in blacks and is often part of 
the cDe (R0) haplotype. Weak D donors are of greater concern because of their 
immunogenicity in stimulating D-negative recipients. 
 
1.4.4.1.3 Weak D: Position effect 
 
The Ce (r') gene paired with a CDe (R1) or a cDe (R0) gene weakens the expression of the 
D antigen due to the inheritance of C in the trans position to D. Genes inherited in trans are 
inherited on opposite chromosome (McCullough, 2011). This type of weak D antigen is 
usually detected by the indirect antiglobulin test (IAT) using anti-D without additional 
testing because of the increased sensitivity of monoclonal reagents. The occurrence of the 
Ce (r') gene is less than 2%.  
 
Nevertheless, the expression of D is normal when the haplotype producing the weakly 
expressed D is partnered by another haplotype that encodes neither C nor D (dce or dcE) in 
a different family member (Daniels, 2008).  
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1.4.4.1.4 Weak D: Partial D 
 
Weak D must be properly distinguished from partial D. A weak D reflects 
a quantitative variation of D antigen, while partial D reflects a qualitative variation of D 
antigen. The D antigen is a structure consisting of at least four parts. If one or more parts of 
the antigen is missing, the remaining antigen can be weakly expressed due to the altered 
protein structure. These individuals can produce an alloantibody to the part they are 
missing, if alloimmunized to D antigen. For this reason, partial D individuals should 
receive Rh negative blood when transfused (Kelton et al., 1984). Conversely, partial D 
individuals should be labeled as D-positive when they are donating their blood. 
 
Older terminology classified partial D as D mosaic or D variant. Different part of D on the 
outer surface of the red cell membrane will determine the different phenotypes of partial D. 
In the past, only seven partial D phenotypes are established. These reaction patterns were 
then expanded to nine patterns which are classified by their parts or epitopes (Lomas et al., 
1993). 
 
Apparent gene conversion occurs between RHCE and RHD polypeptide results in chimeric 
Rh protein. Some replacements produce partial D phenotypes with strongly expressed D 
epitopes (e.g., DIII, DIVa), while others have variable expression of the relevant epitopes 
(e.g., DVa, DVII). In contrast, weak partial D phenotypes (e.g., DVI Type I, DAR) have 
extremely weakly expressed epitopes (ME and C., 2004). 
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1.4.4.1.5 Significance of testing for weak D 
 
The AABB Standards entails testing for weak D on all donor red cells that do not directly 
agglutinate with anti-D antigens (Carson, 2011). Donor center typing procedures should 
detect and label weak D-positive units as D-positive and should be transfused only to D-
positive recipients. An autocontrol is an important part of the weak D test, which verifies 
that a positive result is not due to red cells already coated with antibodies. It is an in vitro 
test which the RBCs and plasma of the patient are combined and tested under the same 
conditions. The test is invalid if red cells are coated with IgG antibodies before testing with 
anti-D at the anti-globulin phase and additional procedures are required to determine the D 
antigen status of the donor (Blaney and Howard, 2013). 
 
Testing for weak D on potential transfusion recipient samples is not mandatory. Some 
facilities test for weak D on recipient samples. D-positive blood is provided if a weak D is 
detected. Although unlikely, a patient with a weak D because of the partial D phenotype 
can produce anti-D theoretically. The partial D phenotype is rare and with current 
monoclonal reagents usually does not require the anti-globulin test for detection. 
 
From a clinical standpoint, weak D testing is performed on prenatal or antepartum 
evaluations and Rh immune globulin (RhIg) work-ups. RhIg is given when a D-negative 
mother has a baby that is D-positive. RhIg suppresses the immune response after exposure 
to D-positive fetal red cells and prevents the mother from producing anti-D. Though RhIg 
can help to prevent Rh sensitization, it cannot prevent damage to D-positive fetal red cells 
if the mother is sensitized to the Rh factor beforehand. RhIg given to D-negative mother at 
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28 weeks of gestation and again within 72 hours of delivery of n D-positive infant has a 
success rate of greater than 99% (Obstetricians and Gynecologists, 1999). 
 
Alloimmunisation occurs in D-negative mothers when exposed to D-positive red cells 
during pregnancy and in D-negative individuals following blood transfusions of D-positive 
blood. For this reason, determination of strong immunogenic RHD alleles is of utmost 
important in clinical practices (Rizzo et al., 2012). 
 
 1.4.4.2    Other Rh group antigens 
 
The Rh blood group system is comprised of some 50 different antigens. Other than antigen 
D, C, c, E and e, other antigens are alternate variations produced by the RHCE and RHD 
genes. These antigens and corresponding antibodies are seldom encountered or have rare 
clinical relevance. Each antigen is assigned a number, and CEST or RH57 is the highest 
number given according to ISBT standardized numeric terminology. Actually it is not a 
correct reflection of the antigens encountered since many antigens such as Rh38 have been 
combined, others have been relocated to other groups or else removed (Ouchari et al., 
2013). 
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1.4.4.2.1   Compound antigens 
 
Examples of compound antigens in the Rh blood group system include the following: 
 
 Rh6 (ce or f) 
 Rh7 (Ce) 
 Rh27 (cE) 
 Rh22 (CE) (Blaney and Howard, 2013) 
 
When certain genes code for an additional protein, a compound antigen is the additional 
antigen product formed. Let's say: when c and e are inherited as RHce, f antigen is 
expressed in addition to the c and e antigens and absent if the person does not inherit that 
particular allele. This means that the Rh haplotypes R0 and r are f-positive, since both 
haplotypes comprise the RHce allele. Since most D-negative people carry the rr haplotype, 
f is present in the infinite majority of D-negative individuals. The f antigen is not really 
'compound', in that it is not formed by the mere presence of c and e on the same red cell, 
but rather by the action of the Rhce allele that also encodes both c and e (Rudmann, 2005).  
 
Antibodies to compound antigens are rarely encountered. If they are identified, locating 
antigen-negative units would require the use of common antisera such as anti-C, anti-c, 
anti-E and anti-e. When transfusion of  RBCs are required, red cell units that are negative 
for one of the antigens creating the compound antigen can be securely transfused (Blaney 
and Howard, 2013). 
20 
 
1.4.4.2.2 G antigens 
 
Genes that code for RhD, RhCe and RhCE also code for a particular amino acid which 
results in an antigen called G. Unlike the five major Rh antigens, an antibody to G reacts 
with cells that are either D-positive or C-positive. It simply cells that are negative 
for both the D and the C antigen are negative for the G antigen. An individual who carry 
either one of the RhD, RhCe and RhCE alleles will have G antigen (Blaney and Howard, 
2013). 
 
Biochemically, the G antigen results when serine is found at position 103. In cells that are 
G-, proline is found at amino acid 103. In routine antibody identification studies, anti-G 
appears to be anti-D and anti-C. Adsorption and elution studies using r' and R0 cells are 
necessary in distinguishing anti-G, anti-D and anti-C antibodies (Rudmann, 2005). 
 
Exposure of D- and C- people to D-, C+ blood through transfusion or pregnancy could 
stimulate anti-C and anti-G antibodies. From previous experience, the stimulated G is quite 
antigenic and therefore clinically significant. It is important to test all Rh negative donors 
with anti-G antibodies (Allen and Tippett, 1958). 
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1.4.4.3     Unusual phenotype 
 
Unusual phenotypes in the Rh blood group system are seldom encountered in routine blood 
bank testing. Unusual phenotypes include cells that have undetectable Rh blood group 
system antigen expression. Understanding the inheritance patterns and cell characteristics 
of unusual phenotypes provides insight into the genetics and biochemistry of the system 
(Blaney and Howard, 2013).  
 
1.4.4.3.1  D-Deletion phenotype 
 
Individuals who have the D-deletion phenotype may produce an antibody that reacts as a 
single specificity (anti-Rh17) or separable specifications such as anti-e and anti-C. An 
individual who produces anti-Rh17 would require D-deleted RBC units if transfusions are 
necessary. It will be difficult to find compatible blood but must be used for transfusion 
without untoward effects. The D-deletion phenotype is written as -D- or D-- (Blaney and 
Howard, 2013). 
 
To identiﬁed the RHD deletion site, the most direct approach would be polymerase chain 
reaction (PCR) ampliﬁcation spanning the RHD deletion site. In 2000, a model of the RH 
gene locus, identiﬁed the RHD deletion site in the prevalent D-negative haplotypes in 
whites. PCR methods was then developed and proved for the discrimination of 
RHD+/RHD+ and RHD+/RHD- individuals. In consequence, direct testing for the presence 
of the RHD deletion is now routinely feasible (Wagner and Flegel, 2000). 
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1.4.4.3.2 Rhnull and Rhmod phenotype 
 
Individuals who do not express any Rh antigens on their red cells are termed Rhnull. Rare 
individuals lack all the Rh antigens with frequency of approximately 1 in 6 million 
individuals. Cells that typed as Rhnull are associated with deficient of LW and Fy5 and show 
markedly decreased expression of S, s and U antigens. The red cells of these individuals 
have impaired sodium and potassium ion transport. This results in hemolytic anemia of 
varying severity characterized stomatocytes, spherocytes, increased RBC osmotic fragility 
and elevated sodium potassium ATPase activity (Cartron, 1999, Qureshi et al., 2010). Null 
phenotypes are apparently disadvantageous, associated with diseases or in capacitating 
conditions, either obligatory or under stress factors (Flegel, 2010). 
 
The Rhnull phenotype can be produced from at least two distinct genetic mechanisms. The 
inheritance of the Rhnull phenotype can result from a regulator gene or an amorph gene. A 
regulator gene, RHAG is inherited on chromosome 6 and codes for thirtieth named blood 
group system. Although the RHAG blood group system does not carry any Rh antigens, its 
presence is essential for the expression of the Rh system antigens. The amorph type of 
Rhnull phenotype is less well understood. The RHD gene is deleted, and there is molecular 
change in RHCE gene, causing neither protein to be produced. Both genotypes result in the 
same clinical syndrome (Qureshi et al., 2010). 
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The Rhmod phenotype is analogous to the regulator Rhnull. In Rhmod phenotype, red cells lack 
most of their Rh antigen expression as a result of the inheritance of a modified RHAG 
gene. Hemolytic anemia is also a characteristic of Rhmod phenotype (Blaney and Howard, 
2013). 
 
1.4.5   Prevalence of Rh haplotypes 
 
There are eight possible common Rh gene haplotypes with their diverse frequency in 
certain populations (Table 1.3) (Knight, 2012). Note that the gene combination Dce (R0) 
haplotypes is seen much more common in Black population than the other population, 
whereas the DCE (R1) haplotype is much more common in Asian population rather than the 
other populations. Haplotype dce (r) is more frequent in white people (37%) than in black 
people (26%). D- as a whole is rare in the Asian population comparing to other populations.  
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Table 1.3: Eight common Rh haplotypes together with their frequencies in certain 
population 
 
 
1.4.6   Inheritance of Rh 
 
Inheritance of the Rh genes is relatively straightforward. Nonetheless, rather in the same 
way that the MS, Ms, NS and Ns antigens are passed on as a 'block', Ce, CE, ce and cE are 
also passed on as a 'block'. This is not surprising when one considers that the genes for the 
antigens are mapped so closely to one another, and the antigens are formed by amino acids 
on the same polypeptide. Although the RHD gene is a separate entity to the RHCE gene 
and the D antigen is on a separate polypeptide, RHD and RHCE are almost always passed 
on as entity (Knight, 2012). 
 
